NCT03207503

Brief Summary

The aim of this study is to test a model of demographic (age, sex), clinical, cognitive, and neurocircuitry predictors of emotion regulation ability and long-term depressive symptoms.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
296

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2017

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 30, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 2, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

October 10, 2017

Completed
6.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2023

Completed
Last Updated

December 20, 2023

Status Verified

December 1, 2023

Enrollment Period

6.1 years

First QC Date

June 30, 2017

Last Update Submit

December 14, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Success of emotion regulation strategy use.

    Self-reported negative affect and arousal following the use of reappraisal and distraction strategies

    baseline

  • Depression symptom severity

    Severity of depressive symptoms as measured by self report

    6 months

  • Depression symptom severity

    Severity of depressive symptoms as measured by self report

    12 months

Study Arms (2)

MDD patients

Participants ages 35-75 determined to be clinically depressed via structured clinical interview. No interventions will be administered as part of this study.

Procedure: fMRI

non-MDD patients

Participants ages 35-75 determined to be lifetime free of psychiatric conditions as assessed by structured clinical interview. No interventions will be administered as part of this study.

Procedure: fMRI

Interventions

fMRIPROCEDURE

Patients will undergo fMRI imaging to assess areas of the brain that are active during emotion regulation. No clinical benefit of MRI imaging is anticipated.

MDD patientsnon-MDD patients

Eligibility Criteria

Age35 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

100 MDD and 100 non-depressed (ND) adult qualifying participants ranging in age from 35-75

You may qualify if:

  • age 35-75
  • No MRI contra-indications (e.g., metal in body)
  • Not currently pregnant
  • Ambulatory
  • No known uncorrected sensory deficits
  • Estimated verbal IQ of 85+ as indicated by the North American Adult Reading test MDD group: Current MDD assessed by history of MDD as assessed by standardized SCID interview
  • Control Group: no lifetime of history of MDD as assessed by standardized SCID interview

You may not qualify if:

  • History of moderate or severe substance dependence, as assessed by standardized SCID interview
  • History of psychosis, mania, or eating disorders, as assessed by standardized SCID interview
  • Disorders with impact on brain characteristics (e.g., epilepsy, Parkinson's Disease) or history of stroke
  • Contraindications to MRI scanning, as indicated on the MRI safety screening questionnaire
  • Use of antidepressants or other psychotropics other than sleep aids in the past 4 weeks (8 weeks for fluoxetine)
  • Indication of mild cognitive impairment or dementia. To meet screening criteria, participants must meet all of the following:
  • Scoring of 24 or higher on the Montreal Cognitive Assessment;
  • perform above 1.5 standard deviations on the following measures: HVLT delayed recall, Trail Making B, and Animal Naming based normative values

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Civitan Building, Duke Psychiatry and Behavioral Sciences

Durham, North Carolina, 27705, United States

Location

Psychiatry and Behavioral Services

Durham, North Carolina, 27705, United States

Location

Related Publications (4)

  • Nienhuis FJ, van de Willige G, Rijnders CA, de Jonge P, Wiersma D. Validity of a short clinical interview for psychiatric diagnosis: the mini-SCAN. Br J Psychiatry. 2010 Jan;196(1):64-8. doi: 10.1192/bjp.bp.109.066563.

    PMID: 20044664BACKGROUND
  • Winecoff A, Labar KS, Madden DJ, Cabeza R, Huettel SA. Cognitive and neural contributors to emotion regulation in aging. Soc Cogn Affect Neurosci. 2011 Apr;6(2):165-76. doi: 10.1093/scan/nsq030. Epub 2010 Apr 12.

    PMID: 20385663BACKGROUND
  • Levenson RW, Carstensen LL, Friesen WV, Ekman P. Emotion, physiology, and expression in old age. Psychol Aging. 1991 Mar;6(1):28-35. doi: 10.1037//0882-7974.6.1.28.

    PMID: 2029364BACKGROUND
  • Knight BG, Maines ML, Robinson GS. The effects of sad mood on memory in older adults: a test of the mood congruence effect. Psychol Aging. 2002 Dec;17(4):653-61. doi: 10.1037//0882-7974.17.4.653.

    PMID: 12507361BACKGROUND

MeSH Terms

Conditions

Depressive Disorder, Major

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Study Officials

  • Moria Smoski, PhD

    Duke Department of Psychiatry

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 30, 2017

First Posted

July 2, 2017

Study Start

October 10, 2017

Primary Completion

November 20, 2023

Study Completion

November 20, 2023

Last Updated

December 20, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will share

This study qualifies as a NDA data sharing study under NIMH guidelines, therefore data will be shared to NDCT.

Locations